deferasirox has been researched along with Arrhythmia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegra, S; Avataneo, V; Cusato, J; D'Avolio, A; De Francia, S; De Nicolò, A; Longo, F; Massano, D; Piga, A; Pirro, E | 1 |
| Amendola, G; Casale, M; Cozzolino, D; De Michele, E; Filosa, A; Musallam, KM; Palmieri, F; Perrotta, S; Pugliese, U; Ragozzino, A; Rispoli, G; Roberti, D; Scianguetta, S; Signoriello, G; Tartaglione, I | 1 |
| Bina, P; Cossa, S; Danjou, F; Defraia, E; Dessì, C; Foschini, ML; Galanello, R; Leoni, G; Matta, G; Morittu, M; Origa, R | 1 |
3 other study(ies) available for deferasirox and Arrhythmia
| Article | Year |
|---|---|
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients.
Topics: Adult; Aged; Alleles; Arrhythmias, Cardiac; ATP Binding Cassette Transporter, Subfamily G, Member 2; beta-Thalassemia; Cytochrome P-450 CYP1A1; Deferasirox; Female; Ferritins; Humans; Iron Overload; Linear Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Vitamin D; Vitamin D3 24-Hydroxylase | 2018 |
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function.
Topics: Arrhythmias, Cardiac; beta-Thalassemia; Blood Transfusion; Child; Child, Preschool; Deferasirox; Disease Management; Female; Humans; Infant; Iron Chelating Agents; Iron Overload; Magnetic Resonance Imaging; Male; Retrospective Studies; Stroke Volume; Treatment Outcome | 2019 |
Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major.
Topics: Adult; Area Under Curve; Arrhythmias, Cardiac; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Humans; Iron; Iron Chelating Agents; Iron Overload; Magnetic Resonance Imaging; Male; Myocardium; Patient Compliance; Predictive Value of Tests; Pyridones; Risk; ROC Curve; Sampling Studies; Transfusion Reaction; Triazoles; Young Adult | 2013 |